Cleared Traditional

K021762 - BCLEAR

K021762 is an FDA 510(k) clearance for BCLEAR, manufactured by Lumenis, Inc.. The device is a Class 2 General & Plastic Surgery device with product code FTC cleared through the Traditional 510(k) pathway after a 86-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2002
Decision
86d
Days
Class 2
Risk

K021762 is an FDA 510(k) clearance for the BCLEAR. Classified as Light, Ultraviolet, Dermatological (product code FTC), Class II - Special Controls.

Submitted by Lumenis, Inc. (Pleasanton, US). The FDA issued a Cleared decision on August 23, 2002 after a review of 86 days - a notably fast clearance cycle.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.4630 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Lumenis, Inc. devices

FDA 510(k) Submission Details - K021762

510(k) Number K021762 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 29, 2002
Decision Date August 23, 2002
Days to Decision 86 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
29d faster than avg
Panel avg: 115d · This submission: 86d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FTC Device Classification - Class 2, Special Controls

Product Code FTC Light, Ultraviolet, Dermatological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 878.4630
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Peers - FTC Light, Ultraviolet, Dermatological

All 51
Devices cleared under the same product code (FTC) and FDA review panel - the closest regulatory comparables to K021762.
PANOSOL II TRU-BLU, MODEL UBL-417
K070934 · National Biological Corp. · May 2007
CYNOSUREA ECLILITE AND ECLILITE U
K050080 · Cynosure, Inc. · May 2005
HOUVA 3 PHOTOTHERAPY SYSTEM
K041212 · National Biological Corp. · Jun 2004
HANDISOL WOUND HEALING
K982082 · National Biological Corp. · Oct 1998
UVISOL AND UVISOL II
K934808 · National Biological Corp. · Dec 1993
PHOTOTHERAPY TIMER
K924969 · National Biological Corp. · Feb 1993